Last reviewed · How we verify

NCT04799171: MoTrMito

Aging and the Mitochondrial Response to Exercise Training, Measured by Noninvasive 31P Magnetic Resonance Spectroscopy

Completed NA Last updated 22 August 2025
What this trial tests

NA trial testing Isometric Contraction Exercise - Young Adults (Age group 18-39) in Physical Activity in 352 participants. Completed in 12 May 2025.

Timeline
2 August 2021
Primary endpoint
12 May 2025
12 May 2025

Quick facts

Lead sponsorPennington Biomedical Research Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment352
Start date2 August 2021
Primary completion12 May 2025
Estimated completion12 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Pennington Biomedical Research Center — full company profile →

Who can join

18 and older, any sex, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to determine whether aerobic or resistant exercise can improve in vivo mitochondrial capacity of skeletal muscle cells similarly in healthy younger, middle aged and older adults. This confers long-term changes in this tissue which in-turn contribute to improved metabolic health and functional capacity through epigenetic regulation of novel exercise response genes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Pennington Biomedical Research Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04799171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing